Teva Pharmaceuticals
TEVA
TEVA
794 hedge funds and large institutions have $26B invested in Teva Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 268 increasing their positions, 323 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less capital invested
Capital invested by funds: $30B → $26B (-$3.92B)
15% less funds holding in top 10
Funds holding in top 10: 41 → 35 (-6)
17% less repeat investments, than reductions
Existing positions increased: 268 | Existing positions reduced: 323
Holders
794
Holding in Top 10
35
Calls
$595M
Puts
$620M
Top Buyers
| 1 | +$273M | |
| 2 | +$260M | |
| 3 | +$178M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$166M |
| 5 |
JPMorgan Chase & Co
New York
|
+$158M |
Top Sellers
| 1 | -$370M | |
| 2 | -$282M | |
| 3 | -$272M | |
| 4 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
-$247M |
| 5 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
-$170M |